| Literature DB >> 1324784 |
Y Takaishi1, K Ujita, H Tokuda, H Nishino, A Iwashima, T Fujita.
Abstract
To search for possible antitumor promoters, we carried out a primary screening of thirty-seven dihydroagarofuran sesquiterpenes from Tripterygium wilfordii Hook fil. var. regelii Makino and Euonymus sieboldianus Blume, using their possible inhibitory effects on the Epstein-Barr virus early antigen (EBV-EA) activation which is induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells. Some of these sesquiterpenes, triptofordin F-2 (Takaishi et al., 1988), 1,2,6,8,15-pentaacetoxy-9-benzoyloxy-4-hydroxy-beta-dihydroagarofuran and triptogelin A-1 (Takaishi et al., 1990) were observed to significantly inhibit the EBV-EA activation at low doses. Based on the results, the structural requirements for the activity of these compounds were discussed [corrected].Entities:
Mesh:
Substances:
Year: 1992 PMID: 1324784 DOI: 10.1016/0304-3835(92)90208-d
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679